IMMUNOPRECISE ANTIBODIES LTD (IPA)

Company Profile

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The company is headquartered in Victoria, British Columbia and currently employs 102 full-time employees. The company leverages systems biology, multiomics modelling and artificial intelligence systems to support its technologies in bioplatform-based antibody discovery. Its services include highly specialized, full-continuum therapeutic biologics discovery, development, and out-licensing to support its business partners to discover and develop novel biologics. The company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases. The company offers services, such as immunogen design and manufacturing, B cell sorting incorporating its function-first B cell screening and sequencing, and the production and screening of custom, immune, and naive phage display libraries. The company also operates LSA instrument platform, which is a provider of high-throughput large and small molecule screening and characterization solutions.

Company Info

IMMUNOPRECISE ANTIBODIES LTD

3204-4464 Markham St

Victoria BRITISH COLUMBIA

P: 12504830308

Employees: 87

Website: https://www.ipatherapeutics.com/